Drug Development

Platform combines proprietary new technologies for high yield purification of exosomes: Kryptonase™ and CIMmultus™ EV monolithic column
| 2 min read

Platform combines proprietary new technologies for high yield purification of exosomes: Kryptonase™ and CIMmultus™ EV monolithic column